
Digoxin attenuates bisphosphonate related osteonecrosis of the jaws by RORγt-dependent Th17 response in male rats
2024; Elsevier BV; Volume: 138; Issue: 6 Linguagem: Inglês
10.1016/j.oooo.2024.08.013
ISSN2212-4411
AutoresJosé Vitor Mota Lemos, Joyce Ohana de Lima Martins, Larissa Carvalho Machado, Lara Rabelo Aragão, Maria Elisa Quezado Lima Verde, Cláudia Pessoa, Maria Júlia Barbosa Bezerra, Ana Paula Negreiros Nunes Alves, Paulo Goberlânio de Barros Silva,
Tópico(s)Fibroblast Growth Factor Research
ResumoThe study aimed to evaluate digoxin, an RORγt inhibitor, in Medication-Related Osteonecrosis of the Jaws (MRONJ) in male rats treated with zoledronic acid (ZA).
Referência(s)